Trial Profile
A Phase I, Randomised, Single-blind Study to Asses the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of AZD9567 in Healthy Volunteers Using Prednisolone as Positive Control
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Mizacorat (Primary) ; Prednisolone
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors AstraZeneca
- 16 Jun 2018 Results presented at the 19th Annual Congress of the European League Against Rheumatism
- 17 Oct 2017 Status changed from recruiting to completed.
- 25 Aug 2017 Planned End Date changed from 4 Sep 2017 to 16 Oct 2017.